Regulation ofµ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance

Pharmacological Reviews - Tập 65 Số 1 - Trang 223-254 - 2013
John T. Williams1,2,3,4,5,6,7,8,9, Susan Ingram1,2,3,4,5,6,7,8,9, Graeme Henderson1,2,3,4,5,6,7,8,9, Charles Chavkin1,2,3,4,5,6,7,8,9, Mark von Zastrow1,2,3,4,5,6,7,8,9, Stefan Schulz1,2,3,4,5,6,7,8,9, Thomas Koch1,2,3,4,5,6,7,8,9, Christopher J. Evans1,2,3,4,5,6,7,8,9, MacDonald J. Christie1,2,3,4,5,6,7,8,9
1Department of Neurologic Surgery, Oregon Health Sciences University, Portland, Oregon (S.L.I.)
2Department of Pharmacology, University of Washington, Seattle, Washington (C.C.)
3Discipline of Pharmacology, University of Sydney, Sydney, New South Wales, Australia (M.J.C.)
4Hatos Center of Neuropharmacology, University of California at Los Angeles (C.J.E.)
5Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany (S.S.)
6Institute of Pharmacology and Toxicology, University of Magdeburg, Magdeburg, Germany (T.K.)
7Psychiatry and Pharmacology, University of California at San Francisco, San Francisco, California (M.v.Z.)
8School of Physiology and Pharmacology, University of Bristol, Bristol, United Kingdom (G.H.)
9Vollum Institute, Oregon Health Sciences University, Portland, Oregon (J.T.W.)

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1124/pr.55.3.2

Alvarez, 2002, mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization, J Neurosci, 22, 5769, 10.1523/JNEUROSCI.22-13-05769.2002

10.1080/13556210412331308994

Arttamangkul, 2000, Binding and internalization of fluorescent opioid peptide conjugates in living cells, Mol Pharmacol, 58, 1570, 10.1124/mol.58.6.1570

10.1523/JNEUROSCI.0303-06.2006

10.1124/mol.108.048512

10.1186/1471-2164-12-14

10.1124/mol.111.076208

10.1523/JNEUROSCI.3734-11.2012

10.1073/pnas.1936664100

10.1038/sj.bjp.0706315

Bailey, 2003, Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine, J Neurosci, 23, 10515, 10.1523/JNEUROSCI.23-33-10515.2003

10.1124/mol.104.004747

10.1016/j.coph.2004.08.012

10.1111/j.1460-9568.2008.06573.x

10.1111/j.1476-5381.2009.00140.x

Bauldry, 1991, Tumor necrosis factor alpha priming of phospholipase D in human neutrophils. Correlation between phosphatidic acid production and superoxide generation, J Biol Chem, 266, 4173, 10.1016/S0021-9258(20)64303-4

Bellavite, 1988, Activation of NADPH-dependent superoxide production in plasma membrane extracts of pig neutrophils by phosphatidic acid, J Biol Chem, 263, 8210, 10.1016/S0021-9258(18)68464-9

Berger, 2010, How to design an opioid drug that causes reduced tolerance and dependence, Ann Neurol, 67, 559, 10.1002/ana.22002

10.1111/j.1471-4159.2004.02340.x

10.1098/rspb.1983.0093

10.1073/pnas.072075399

10.1016/S1044-7431(03)00173-8

10.1126/science.286.5449.2495

10.1038/35047086

Bohn, 2002, Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice, J Neurosci, 22, 10494, 10.1523/JNEUROSCI.22-23-10494.2002

10.1385/NMM:5:1:041

10.1073/pnas.95.16.9608

10.1042/bj2640617

10.1074/jbc.M300525200

10.1007/s00213-010-1806-y

10.1074/jbc.273.51.34488

10.1042/bj3480531

10.1016/S0959-4388(98)80058-5

10.1016/S1097-2765(01)00189-7

10.1074/jbc.M007437200

10.1124/mol.65.3.528

10.1016/j.neuron.2008.02.006

10.1073/pnas.81.22.7253

10.1523/JNEUROSCI.4170-07.2008

10.1038/nature09789

Christie, 1987, Cellular mechanisms of opioid tolerance: studies in single brain neurons, Mol Pharmacol, 32, 633

10.1038/bjp.2008.100

10.1016/j.cellsig.2008.05.004

10.1016/j.cellsig.2009.12.003

10.1038/nature10488

10.1124/mol.109.060558

Connor, 1996, Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro, Br J Pharmacol, 119, 1614, 10.1111/j.1476-5381.1996.tb16080.x

10.1038/sj.bjp.0702922

10.1038/sj.bjp.0705938

10.1016/B978-0-12-381298-8.00022-8

Corbett, 2006, 75 years of opioid research: the exciting but vain quest for the Holy Grail, Br J Pharmacol, 147, S153, 10.1038/sj.bjp.0706435

10.1073/pnas.86.19.7321

10.1016/j.tips.2005.10.009

10.1017/erm.2012.5

10.1111/j.1476-5381.1968.tb00986.x

10.1523/JNEUROSCI.2499-04.2004

10.1124/mol.105.013185

10.1523/JNEUROSCI.4749-08.2009

10.1523/JNEUROSCI.5999-10.2011

10.1111/j.1476-5381.2011.01482.x

10.1016/S0006-3495(03)74856-5

10.1074/jbc.271.37.22552

10.1021/bi991938b

10.1016/j.pbb.2009.02.004

10.1111/j.1476-5381.2008.00035.x

10.1016/j.expneurol.2005.08.012

10.1111/j.1476-5381.2011.01382.x

10.1111/j.1476-5381.2012.02080.x

10.1016/j.bbalip.2009.05.011

10.1097/00000542-199505000-00018

10.1016/S0006-2952(98)00088-4

Ehlert, 1985, The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium, Mol Pharmacol, 28, 410

Eitan, 2003, Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization, J Neurosci, 23, 8360, 10.1523/JNEUROSCI.23-23-08360.2003

10.1074/jbc.M009571200

10.1016/0196-9781(81)90003-6

10.1016/j.neuropharm.2004.06.016

10.1016/S0028-3908(02)00147-8

10.1016/S0306-4522(02)00930-2

10.1124/mol.110.069096

10.1016/S0896-6273(01)00517-7

Fiorillo, 1996, Opioid desensitization: interactions with G-protein-coupled receptors in the locus coeruleus, J Neurosci, 16, 1479, 10.1523/JNEUROSCI.16-04-01479.1996

10.1016/j.bcp.2011.03.001

10.1124/jpet.110.172643

10.1016/j.brainres.2008.04.036

Gaibelet G, Millot C, Lebrun C, Ravault S, Sauliere A, Andre A, Lagane B, Lopez A (2008) Cholesterol content drives distinct pharmacological behaviours of micro-opioid receptor in different microdomains of the CHO plasma membrane. Mol Membr Biol 25:423–435.

10.1016/j.tips.2007.06.005

10.1124/mol.66.1.97

10.1046/j.1460-9568.2003.02529.x

Goodman, 1998, Role of arrestins in G-protein-coupled receptor endocytosis, Adv Pharmacol, 42, 429, 10.1016/S1054-3589(08)60780-2

10.1074/jbc.M302933200

10.1038/nature11111

10.1016/S0304-3959(99)00281-X

10.1007/s00213-006-0365-8

10.1523/JNEUROSCI.2304-11.2011

10.1074/jbc.M111.248310

Haberstock-Debic, 2003, Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons, J Neurosci, 23, 4324, 10.1523/JNEUROSCI.23-10-04324.2003

10.1523/JNEUROSCI.5045-04.2005

10.1016/S0028-3908(03)00205-3

Harris, 1991, Transient homologous mu-opioid receptor desensitization in rat locus coeruleus neurons, J Neurosci, 11, 2574, 10.1523/JNEUROSCI.11-08-02574.1991

10.1016/S0092-8674(02)00613-X

10.1073/pnas.0907915107

10.1016/S0306-4522(02)00157-4

10.1016/j.brainres.2007.09.096

10.1124/jpet.109.161455

Ingram, 1998, Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway, J Neurosci, 18, 10269, 10.1523/JNEUROSCI.18-24-10269.1998

10.1038/sj.npp.1301634

Inoue, 2000, Protein kinase C-mediated acute tolerance to peripheral mu-opioid analgesia in the bradykinin-nociception test in mice, J Pharmacol Exp Ther, 293, 662

10.1007/s00018-005-5195-z

10.1124/mol.106.022376

10.1159/000093044

10.1083/jcb.201009128

10.1074/jbc.271.32.19021

10.1124/mol.53.3.377

Kelly, 2007, Agonist-selective mechanisms of GPCR desensitization, Br J Pharmacol, 153, S379, 10.1038/sj.bjp.0707604

Kenakin T (1997) Pharmacologic Analysis of Drug Receptor Interaction, Ed. 3rd. Lippincott-Raven, Philadelphia.

10.1124/jpet.110.173948

10.1016/0306-4522(92)90369-D

10.1016/j.cub.2007.12.057

Koch, 1997, Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization, J Neurochem, 69, 1767, 10.1046/j.1471-4159.1997.69041767.x

10.1074/jbc.273.22.13652

10.1124/mol.58.2.328

10.1074/jbc.M100305200

10.1074/jbc.M206709200

10.1046/j.1471-4159.2003.02189.x

10.1124/mol.104.004994

10.1111/j.1471-4159.2006.03736.x

10.1016/j.pharmthera.2007.10.003

10.1111/j.1471-4159.2009.06217.x

10.1074/jbc.272.44.27605

Kovoor, 1998, Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy, Mol Pharmacol, 54, 704

10.1111/j.1471-4159.2007.04738.x

10.1146/annurev.pharmtox.38.1.289

10.1074/jbc.M109.026922

10.1016/j.ejphar.2008.08.025

10.1074/jbc.C000576200

10.1186/1744-8069-7-24

10.1126/scisignal.2001748

10.1146/annurev.pharmtox.40.1.389

10.1111/j.1471-4159.1992.tb08432.x

10.1146/annurev.bi.52.070183.001111

10.1097/00000542-200610000-00027

10.1152/physrev.00005.2009

10.1074/jbc.M109.030411

10.1046/j.1471-4159.2001.00267.x

10.1124/jpet.111.188235

10.1016/0024-3205(89)90272-5

Liscovitch, 1999, Localization and possible functions of phospholipase D isozymes, Biochim Biophys Acta, 1439, 245, 10.1016/S1388-1981(99)00098-0

10.1042/bj3450401

10.1074/jbc.M106104200

10.1016/S0165-0173(01)00057-1

10.1124/mol.60.1.53

10.1016/j.cell.2011.08.043

10.1046/j.0953-816x.2001.01731.x

10.1038/sj.emboj.7600799

10.1124/jpet.109.152157

10.1074/jbc.M604278200

10.1007/s00213-009-1673-6

10.1124/mol.109.062208

10.1038/nature10954

10.1016/0304-3959(96)81972-5

10.1016/j.conb.2007.10.004

10.1111/j.1476-5381.2010.00967.x

10.1038/383819a0

10.1124/mol.59.6.1523

10.1139/o03-079

10.1124/mol.59.6.1360

10.4049/jimmunol.176.11.7039

10.1073/pnas.92.17.7931

10.1124/mol.110.066613

10.1073/pnas.1000751107

Mestek, 1995, The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C, J Neurosci, 15, 2396, 10.1523/JNEUROSCI.15-03-02396.1995

10.1111/j.1471-4159.2009.06156.x

Mjanger, 1991, Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists, J Pharmacol Exp Ther, 258, 544

10.1074/jbc.M109.059410

10.1111/j.1476-5381.2011.01335.x

10.1016/j.pbb.2007.07.002

10.1124/jpet.104.066548

10.1016/S0304-3940(02)00141-6

10.1111/j.1601-183X.2006.00261.x

10.1111/j.1476-5381.1980.tb14553.x

10.1074/jbc.274.45.32248

10.1074/jbc.M910348199

10.1074/jbc.M006198200

10.1111/j.1471-4159.2007.05057.x

10.1111/j.1476-5381.1995.tb15899.x

Ortiz, 1995, Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine, J Neurosci, 15, 1285, 10.1523/JNEUROSCI.15-02-01285.1995

Ozaita, 1998, Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts, J Neurochem, 70, 1249, 10.1046/j.1471-4159.1998.70031249.x

10.1074/jbc.272.40.24961

Paronis, 1997, Ventilation in morphine-maintained rhesus monkeys. II: Tolerance to the antinociceptive but not the ventilatory effects of morphine, J Pharmacol Exp Ther, 282, 355

Pasternak, 2001, Incomplete cross tolerance and multiple mu opioid peptide receptors, Trends Pharmacol Sci, 22, 67, 10.1016/S0165-6147(00)01616-3

10.1016/j.ejphar.2007.01.059

10.1523/JNEUROSCI.4654-10.2011

10.1074/jbc.272.41.25425

10.1111/j.1533-2500.2008.00204.x

10.1016/j.neuroscience.2007.03.029

10.1016/j.cellsig.2006.05.026

10.1074/jbc.273.20.12402

10.1146/annurev.physiol.69.022405.154731

10.1074/jbc.M305857200

10.1124/mol.110.070870

10.1523/JNEUROSCI.4874-10.2011

10.1124/pr.111.004598

10.1016/j.neuropharm.2010.08.003

10.1124/mol.111.072801

10.1016/j.cellsig.2009.07.014

10.1038/nature10361

10.1016/j.cell.2010.10.018

10.1073/pnas.0904509106

Rivero G, Llorente J, McPherson J, Cooke A, Mundell SJ, McArdle CA, Rosethorne EM, Charlton SJ, Krasel C, Bailey CP, Henderson G, Kelly E (2012) Endomorphin-2: A Biased Agonist at the μ Opioid Receptor. Mol Pharmacol. [Epub ahead of print]

Rodriguez-Martin, 2008, Methadone: does it really have low efficacy at micro-opioid receptors?, Neuroreport, 19, 589, 10.1097/WNR.0b013e3282f97b64

10.1038/nature09665

10.1016/S0304-3959(97)00093-6

10.1016/0006-291X(90)91711-Z

10.1002/syn.20723

10.1016/j.cellsig.2005.08.005

10.1074/jbc.M109.076695

10.1046/j.1471-4159.2000.0740414.x

Schulz, 1980, Lack of cross-tolerance on multiple opiate receptors in the mouse vas deferens, Mol Pharmacol, 18, 395

10.1038/sj.emboj.7600334

10.1073/pnas.83.24.9408

Sim-Selley, 2000, Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain, J Neurosci, 20, 4555, 10.1523/JNEUROSCI.20-12-04555.2000

10.1038/sj.bjp.0702771

10.1016/S0006-8993(03)03170-6

10.1016/j.pain.2006.08.009

10.1124/pr.110.002667

10.1016/j.neulet.2004.05.046

Sosnowski, 1990, Differential cross-tolerance between intrathecal morphine and sufentanil in the rat, Anesthesiology, 73, 1141, 10.1097/00000542-199012000-00012

10.1016/S0091-3057(01)00525-1

10.1073/pnas.93.17.9241

10.1016/j.sbi.2011.06.011

Stevens, 1989, Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord, J Pharmacol Exp Ther, 251, 216

10.1016/j.drugalcdep.2011.10.025

10.1529/biophysj.104.048538

10.1074/jbc.M502352200

Tan, 2003, Phosphoinositide 3-kinase cascade facilitates mu-opioid desensitization in sensory neurons by altering G-protein-effector interactions, J Neurosci, 23, 10292, 10.1523/JNEUROSCI.23-32-10292.2003

10.1074/jbc.M806742200

10.1074/jbc.M304504200

10.1074/jbc.M806588200

10.1038/sj.bjp.0705595

Terwilliger, 1994, Chronic morphine administration increases beta-adrenergic receptor kinase (beta ARK) levels in the rat locus coeruleus, J Neurochem, 63, 1983, 10.1046/j.1471-4159.1994.63051983.x

10.1038/nature11085

Touyz, 1999, Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells, Hypertension, 34, 976, 10.1161/01.HYP.34.4.976

10.1089/ars.2007.1957

10.1016/j.neuroscience.2004.02.019

10.1021/bi0475469

Trujillo KA and Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonists MK-801 Science 251:85-87.

10.1016/S0959-4388(00)00096-9

Umans, 1981, Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice, J Pharmacol Exp Ther, 218, 409

10.1016/S0306-4522(01)00426-2

10.1111/j.1600-0854.2006.00420.x

10.1124/mol.107.042952

10.1016/j.drugalcdep.2010.02.014

10.1016/S0959-4388(03)00069-2

10.1074/jbc.272.24.15569

10.1146/annurev.biochem.73.011303.073940

10.1007/s002130000620

10.1016/j.neuroscience.2006.06.021

10.1523/JNEUROSCI.1157-07.2007

10.1124/jpet.103.054049

10.1016/S0028-3908(99)00174-4

10.1016/S0006-2952(02)01114-0

10.1016/j.neuroscience.2011.12.033

10.1096/fj.08-128348

10.1186/1744-8069-7-68

10.1126/science.6546809

10.1016/j.sbi.2008.09.010

10.1073/pnas.1113645108

10.1073/pnas.95.17.9914

10.1016/S0896-6273(01)80032-5

Williams, 2001, Cellular and synaptic adaptations mediating opioid dependence, Physiol Rev, 81, 299, 10.1152/physrev.2001.81.1.299

10.1124/mol.55.2.263

10.1038/nature10939

10.1124/mol.109.063107

Yang, 1988, Dephosphorylation of the β 2-adrenergic receptor and rhodopsin by latent phosphatase 2, J Biol Chem, 263, 8856, 10.1016/S0021-9258(18)68386-3

10.1074/jbc.272.46.28869

10.1523/JNEUROSCI.4315-08.2009

10.1523/JNEUROSCI.6282-09.2010

10.1016/S0304-3959(01)00353-0

10.1073/pnas.95.12.7157

10.1074/jbc.M807971200

10.1073/pnas.0802253105

10.1124/mol.107.039842

10.1042/BJ20050085